REFERENCES
- Guyot M, Fawaz F. Le choix actuel et future des formes pharmaceutiques administrées par voie intravaginale. I. Les formes dites classiques. J Pharm Belg 1993; 48: 393–406
- Hardy E, de Padua K S, Jimenez A L, et al. Women's preferences for vaginal antimicrobial contraceptives. I. Methodology. Contraception 1998; 58: 233–8
- Hardy E, de Padua K S, Jimenez A L, et al. Women's preferences for vaginal antimicrobial contraceptives. II. Preferred characteristics according to women's age and socioeconomic status. Contraception 1998; 58: 239–44
- Hardy E, de Padua K S, Jimenez A L, et al. Women's preferences for vaginal antimicrobial contraceptives. III. Choice of a formulation, applicator and packaging. Contraception 1998; 58: 245–9
- Hardy E, de Padua K S, Jimenez A L, et al. Women's preferences for vaginal antimicrobial contraceptives. IV. Attributes of a formulation that would protect from STD/AIDS. Contraception 1998; 58: 251–5
- Erny R, Siboni C. Les tampons au chlorure de benzalkonium. Tolérance locale et effets sur la glaire cervicale. J Gynecol Obstet Biol Reprod 1983; 12: 767–74
- Chrétien F C. Etude préliminaire au microscope électronique à balayage des effets d'un spermicide tensio-actif cationique sur la membrane plasmique des spermatozoïdes. Contracept Fertil Sex 1986; 14: 11–21
- Bourbon P, Thuries S, Zerbib D. Les ammoniums quaternaires en thérapeutique locale vaginale. Rev Fr Gynecol Obstet 1989; 84: 775–7
- Bourbon P, Thuries S, Zerbib D. Etude du pouvoir antiseptique de dix molécules utilisées en thérapeutique locale. J Med Prac 1989; 34: 9–11
- Wainberg M A, Spira B, Bleau G, et al. Inactivation of human immunodeficiency virus type 1 tissue culture fluid and in genital secretions by the spermicide benzalkonium chloride. J. Clin Microbiol 1990; 28: 156–8
- Cherman J C, Barre F Sinoussi, Henin Y, et al. HIV inactivation by a spermicide containing benzalkonium chloride. AIDS Forschung (AIFO) 1987; 2: 85–6
- Les comportements sexuels en France. Rapport au Ministre de la Recherche et de l'Espace. ACBF Group, Paris 1993
- Chi I C, Smith S C, Borko E, et al. Clinical acceptability, use patterns and use effectiveness of the vaginal contraceptive sponge and Neosampoon® tablets. An international multi-center randomized clinical trial. Contraception 1987; 36: 499–512
- Hira S K, Springt A B, Fedblum P J, Sunkutu M R, Glover L H, Steiner M J. Spermicide acceptability among patients at a sexually transmitted disease clinic in Zambia. Am J Public Health 1995; 85: 1098–103
- Levrier M. Comprimés vaginaux, pilules et stérilets: étude de pathogénicité comparée. Rev Fr Gynecol Obstet 1989; 84: 205–10
- Chvapil M, Eskelson C D, Stiffel V, Owen J A, Droegemueller W. Studies on nonoxynol 9. II. Intravaginal absorption, distribution, metabolism and excretion in rats and rabbits. Contraception 1980; 22: 325–39
- Buttar H S. Transvaginal absorption and disposition of nonoxynol-9 in gravid rats. Toxicol Lett 1982; 13: 211–16